The effects of interferons (IFNs) on lymphocyte adhesion to cultured human vascular endothelial cells (EC) were investigated using an in, vitro assay. Endothelial cells obtained from umbilical vein were first cultured at a low density 'with a conditioned medium (CM) from 12-0-tetra decanoylphorbol 13-acetate-concanavalin A (TPA-Con A) stimulated human peripheral blood lymphocytes (PBL), or with recombinant (r) gamma interferon (IFN-7y) or r alpha interferon (IFN-x), and then were incubated with freshly isolated PBL. Natural IFN-'Y in the TPA-Con A CM and rIFN-7 (12.5-500 U/ml) induced major histocompatibility complex-class II antigens (HLA-DR, HLA-DP, and HLA-DQ) and significant lymphocyte adhesion to the EC, whereas rIFN-a did not, The lymphocyte adhesion to the EC and the expression of DR antigens on the EC were well correlated in terms of both kinetics and the dose-response pattern of rIFNy. When EC expressing I region associated (Ia) antigen were preincubated with monoclonal anti-DR antibody before the addition of lyunjhocytes, the lymphocyte adhesionwas significantly inhibited in both allogeneic and syngeneic combinations, whereas anti-HLA-DP, anti-HLA-DQ, and anti-HLA-ABC antibodies sdid not inhibit the binding at all. Cell fractionation experiments indicated that the majority of lymphocytes adhering to la-expressed EC were Leu-3' T cells, whose binding was again almost completely inhibited by anti-DR antibody. .Moreover, anti-Leu3a, but not anti-Leu-2a, antibody effectively inhibited the. T cell adhesion to the EC. These results strongly suggest that the interaction of the Leu-3(T4) receptor ofT cells with IFN-y-induced DR antigens on EC plays a central role in the selective adhesion of Leu-3' T cell to EC.
Introduction
Accumulation and in situ activation ofsensitized T cells in nonlymphoid tissues where triggering antigens are localized,.is considered to be the initial event in local cell-mediated immune responses, such as delayed-type hypersensitivity, allograft rejection, and allergic neuritis ( 1, 2) . In these lesions, the lymphocyte traffic dramatically increases from blood through the inflammatory site into afferent lymph (3) (4) (5) . However, the lymphocyte migration from blood is not random, and distinct populations of Iymphocytes can be directed selectively to sites of local immune responses (6) (7) (8) (9) . For example, a recent study in human skin allografts has shown that helper/inducer T cells predominantly infiltrate the graft dermis and graft bed and have a different distribution pattern from that of suppressor/cytotoxic T cells (6) .
The selective migration of lymphocytes to particular lymphoid organs or sites of chronic inflammation raises two basic questions: first, whether or not the selectivity depends on a specific recognition between lymphocytes and vascular endothelial cells (EC)' in the adhesion process, which is the important initial step of lymphocyte migration through microvessels (10) , and second, what controls the increased lymphocyte adhesion on the surface of microvessels in the site of chronic inflammation. As for the former, accumulated evidence shows that the binding between organ-specific determinants on EC of postcapillary high endothelial venules (HEV), in particular, lymphoid organs and corresponding receptor molecules oflymphocytes, was involved in the selective migration oflymphocytes into lymph nodes (11) (12) (13) . Recently, lymphocyte receptors specific for the endothelial determinants in lymph nodes have been elucidated by direct biochemical isolation (14) as well as by monoclonal antibody (15). As for the latter, little is known about the exact mechanisms involved in the lymphocyte entry through microvessel into chronic inflammatory sites.
In this study, we tried to analyze the mechanisms of lymphocyte adhesion to EC using cultured human umbilical EC. The results clearly indicated that Leu-3+ (helper/inducer) T cells recognized the major histocompatibility complex (MHC) class II antigens, especially DR antigens, on EC induced by gamma interferon (IFN-y) and adhered tightly onto the EC.
Methods
Isolation and culture ofEC. The EC were obtained by treating a fresh human umbilical vein with 0.1% collagenase (Sigma Chemical Co., St. Louis, MO) in phosphate-buffered saline (PBS), as described by Jaffe et al. (16) . The EC were then suspended in medium 199 (M199) (Nissui Pharmaceutical Co., Tokyo) supplemented with 10% unheated human serum (HS) (pooled in our laboratory), 100 U/ml penicillin, 100 pg/ml streptomycin, 2 mM L-glutamine, and 15 mM Hepes (Sigma Chemical Co.), and were cultured in 60-mm culture dishes (Nunclon, Nunc, Denmark). The EC thus obtained were morphologically homogeneous and showed positive immunofluorescence with a rabbit anti-Factor VIII antiserum (Behring Diagnostic, Somerville, NJ). The cultures were incubated at 370C in a humidified 5% CO2, 95% air environment. The culture medium was changed every 2-3 d. The EC were serially passed by brief exposure to 0.25% trypsin (Difco Laboratories, Inc., Detroit, MI) and 0.04% EDTA (Sigma Chemical Co.). In this study, EC were used from four passages only.
Preparation oflymphocytes. Human peripheral blood lymphocytes (PBL) were prepared from heparinized venous blood by Ficoll-Hypaque density gradient centrifugation. The PBL were washed twice in PBS and resuspended in RPMI 1640 (Nissui Pharmaceutical Co., Tokyo, Japan) containing 5% fetal calf serum (FCS) (Flow Laboratories, Inc., McLean, VA), 100 U/ml penicillin, 100 Ag/ml streptomycin, and 2 mM glutamine.
The monocytes were removed by being passed through a Sephadex G-10 column (Pharmacia Fine Chemicals AB, Uppsala, Sweden) as described by Ly and Mishell (17) . The nonadherent cells contained <1% monocytes as determined by peroxidase staining.
Separation ofT and non-T cells. T cell-enriched fraction and T celldepleted fraction were separated by the sheep erythrocyte-rosetting method as described elsewhere (18). Briefly, 5 X 106 G-I0 passed lymphocytes and 2 X 108 neuramidase-treated sheep erythrocytes (SRBC) were mixed in 1 ml of RPMI 1640 supplemented with 50% FCS. The mixture was centrifuged for 5 min at 1,000 rpm and incubated at 4VC for 90 min. Using the Ficoll-Hypaque gradient technique, the T cellenriched fraction and T cell-depleted fraction were isolated from the bottom and the interface layers, respectively. After the SRBC had been lysed with distilled water, each fraction of lymphocytes was suspended in M199. The T cell-enriched fraction contained >85% erythrocyte (E) rosette-forming cells and the T cell-depleted fraction contained <5% E rosette-forming cells. In some experiments, T cell fraction was also prepared by being passed through a nylon-wool column (19) .
Isolation of T cell subsets. Nylon-wool nonadherent lymphocytes served as a source of cells for the isolation of T cell subsets. Helper/ inducer T cells and suppressor/cytotoxic T cells were prepared with monoclonal antibodies (Becton-Dickinson & Co., Oxnard, CA) specific for each subset; antibody for suppresser/cytotoxic T cells and Leu-3a for helper/inducer T cells. The T cell subsets were separated by using the method of Van Epps et al. (20) . Briefly, lymphocytes were incubated at 4°C for 20 min with 1 Ortho Diagnostic Systems, Inc., Raritan, NJ). In this study, only cell preparations with >90% purity were used.
Preparation of 12-0-tetra decanoylphorbol 13-acetate (TPA) concanavalin A (Con A) conditioned medium (CM). Freshly isolated human PBL (3 X 10' cells/ml) were preincubated with 2 ng/ml of TPA (Sigma Chemical Co.) at 37°C for 4 h. After being washed three times with RPMI 1640, the cells were cultured with Con A (Sigma Chemical Co.), 5 jAg/ml, in RPMI 1640-5% FCS at 37°C in 5% CO2/air. The TPA-Con A CM was harvested after a 72-h incubation, and immediately added to the EC cultures for the lymphocyte-EC adhesion assay and endothelial DR expression assay. The interferon (IFN) activity in the TPA-Con A CM was determined by microcytopathic effect inhibition assay using encephalomyocarditis virus and FL cells (human amnion-derived cell line) as described elsewhere (21 Giemsa-stained.
In the experiments ofsyngeneic combination, EC and umbilical cord blood mononuclear cells were obtained from the same umbilical cord.
The EC harvested by collagenase treatment were further exposed to 0.25% trypsin with 0.04% EDTA, washed twice with PBS, and suspended in M199-10% HS. Subsequent procedures were the same as described above. In all experiments, cultures were set up in duplicate.
Adhesion-positive EC (EC with two or more lymphocytes) were counted in three microscopic fields (2-3 mm2/field) near the center of each coverslip, and the adhesion index (A.I.) was determined as follows: A.I. = Number ofadhesion-positive EC/Number oftotal EC/field. Results were expressed as the mean A.I.±SD of six determinations, since no significant differences were observed between the duplicate cultures in separate statistical analysis. Inhibition of lymphocyte-EC adhesion with monoclonal antibody (Ab) was determined as follows: percent inhibition = A.I. of no Ab treatment -A.I. of Ab treatment/A.I. of no Ab treatment -A.I. of control X 100.
Direct characterization ofadherent lymphocyte subsets by an immunohistochemical method. The subsets of G-10-passed PBL adhering to rIFN-y-treated EC on coverslips were directly stained with anti-Leu series (Becton-Dickinson & Co.) by an indirect immunoperoxidase method. In brief, the coverslips were fixed in cold ethanol and were incubated sequentially in normal goat serum, monoclonal antibody, peroxidase conjugated goat anti-mouse Ig (Cappel Laboratories), 3,3'-diaminobenzidine, tetrahydrochloride (DAB) substrate, after which they were counterstained with methyl green.
Enzyme treatment oflymphocytes. Freshly isolated and G-I0-passed lymphocytes were suspended in PBS (2 X 106 cells/ml) and incubated in a 370C waterbath for 10 min with trypsin (25 ug/ml, Type XIII, Sigma Chemical Co.) in the presence or absence of trypsin soybean inhibitor (25 ;g/ml, Type I-S, Sigma Chemical Co.). After the treatment, the lymphocytes were washed in cold RPMI-5% FCS to remove free enzymes and were resuspended in Ml 99 at a density of 5 X I0O cells/ ml. Part of the trypsinized lymphocytes was further incubated for 12 h in a culture medium.
Statistical analysis. Probability (P) values were determined by using Student's t test.
Results
Effect of TPA-Con A CM on lymphocyte-EC adhesion. When freshly isolated and G-10-passed lymphocytes were incubated with untreated EC, no significant attachment of lymphocytes to the EC was observed. However, once the EC were precultured for 3 d in the presence of 1% TPA-Con A CM, the EC became elongated in shape and significant lymphocyte-EC adhesion was observed within 1 h (Table I ). The control medium containing Con A (5 ,ug/ml) had no such effects.
Since TPA-Con A CM contained IFN activity that was acid labile and neutralized by monoclonal anti-IFN-'y antibody, the majority of IFN in the TPA-Con A CM was thought to be of y type. When EC were cultured with 1% TPA-Con A CM depleted of IFN activity by either acid (pH 2) treatment or monoclonal anti-IFN-y antibody treatment, the adhesion index was found to be significantly, ifnot completely, reduced (Table I ). Therefore, it was suggested that IFN-'y was one of the factors in the CM responsible for the lymphocyte adhesion to EC. This was supported by the similar experiments with rIFN-'y.
Recently, it was reported by Pober et al. (25, 26) that IFN--y was a potent inducer of endothelial DR antigens. In fact, the HLA-DR antigens were expressed on 62 and 100% of the EC cultured for 3 d with 1% TPA-Con A CM and 100 U/ml of rIFN-y, respectively. In contrast, no DR antigens were expressed in the absence of IFN--y activity (Table I) . However, it is also clear from the data presented in Table I that TPA-Con A CM, which had been depleted of IFN activity by either acid treatment or treatment with anti-IFN-'y antibody, still increased the adhesion index substantially, which indicates that there are other mechanisms of lymphocyte-EC binding irrelevant to DR antigens. One such mechanism may be the induction of EC surface adhesiveness by interleukin 1 for several leukocyte classes, including peripheral blood lymphocytes, as reported by Bevilacqua et al. (27) . At the moment, we have no clue as to the function of these mechanisms; therefore, subsequent experiments were focused on the role ofIFN-y and DR antigens in the lymphocyte-EC adhesion, using rIFN-y.
Effect of rIFN-,y on lymphocyte-EC adhesion. The role of IFN-y in the lymphocyte-EC adhesion was further investigated using rIFN-y. After EC had been treated with rIFN-,y (500 U/ml) for 3 d, lymphocytes were added to the EC and incubated for varying periods. As shown in Fig. 1 (Fig. 2 B) in contrast to untreated EC (Fig. 2 A) . The lymphocytes bound to the EC also exhibited changes in cell shape that are characteristic of motile lymphocytes (Fig. 2 C) . In contrast, when EC Since both the adhesion index and the DR expression on the EC showed similar dose-dependent fashion on rIFN-y, we then performed the comparative study of kinetics for both. EC were cultured with 50 U/ml and 200 U/ml ofrIFN-'y for varying periods, and then adhesion index and DR expression were simultaneously assayed. As shown in Fig. 5 (25, 26, 28) . We thus investigated the induction of DR, DP(SB), and DQ(DC) antigens on the EC by rIFN-7, and their role in lymphocyte adhesion. After EC were cultured with 500 U/ml ofrIFN-'y for 4 d, the surface expression Fig. 7 , only anti-DR antibodies significantly, if not completely, inhibited the adhesion in a dose-dependent fashion, whereas anti- Tcell-EC adhesion in syngeneic and allogeneic combinations. Since the EC and T cells used thus far were allogeneic combinations, the possibility existed that the lymphocyte adhesion to rIFN-,y-treated EC merely represented the recognition and binding of endothelial DR antigens by the alloreactive T cells. To exclude this possibility, we performed the same experiments using both syngeneic and allogeneic combinations of EC and T cells. In a syngeneic combination, EC and lymphocytes were prepared from the same umbilical cord. The EC were immediately placed on coverslips and cultured with 500 U/ml ofrIFNy, and the lymphocytes were maintained in a culture medium until use. Three days later, nylon-nonadherent lymphocytes were prepared from the maintained lymphocytes and added to either syngeneic or allogeneic EC. As shown in Table III The experimental conditions and methods were the same as described in Table II (Table IV) . When a trypsin soybean inhibitor was used with trypsin, no inhibition was observed on the lymphocyte-EC adhesion, indicating the specificity of the treatment. However, if the trypsin-treated lymphocytes were further incubated for 12 h in a culture medium in the absence of the enzyme, the binding capacity ofthe lymphocyte was again completely restored. The results thus suggested that trypsin-sensitive Lymphocyte subsets adhering to Ia-expressed EC. Our next question was then to decide which subset of lymphocytes was preferentially responsible for the adhesion to EC. To examine this point, T and non-T cells separated by E-rosette formation were added to EC treated with rIFN-' (500 U/ml) for 3 d. The adhesion index ofT cells (E-rosette positive cells) was comparable to that of unseparated G-10 passed lymphocytes, whereas few non-T cells (E-rosette negative cells) bound to the EC (Table  V) . T cell fraction was then positively separated into Leu-2' and Leu-3' T cells as indicated in Methods, and each population was incubated with EC. The results clearly showed that Leu-3' T cells rather preferentially bound to rIFN--y-treated EC, whereas Leu-2' T cells did so only marginally (Table V) . The binding of Leu-3' T cells, but not Leu-2' T cells, was strongly inhibited by anti-DR antibody (PTF29. 12).
The proportion of adherent T cells in the added T cells was estimated to be 2-3%. To negate that contaminant non-T cells selectively adhered to EC, direct staining of the adherent lymphocyte subsets on coverslips was performed with anti-Leu series by an indirect immunoperoxidase method. When G-10-passed lymphocytes were added to rIFN--y-treated EC, most of the adherent lymphocytes was Leu-4 positive cell as shown in Fig. 8 . In preliminary observations, Leu-4', Leu-3', and Leu-2' lymphocytes on the EC were -85, 65, and 2% of the total adherent lymphocytes, respectively, whereas the proportions ofthe added lymphocytes were -75, 50, and 20%, under light microscopic observation. The results obviously showed a preference in adhesion for Leu-3' T cells over Leu-2' T cells.
It was shown that anti-T4 (Leu-3) antibody inhibits the cytolysis of class II-restricted T4' cytotoxic T lymphocyte clones by blocking the T cell recognition of the nonpolymorphic Ia epitope on target cells (29) (30) (31) . To examine whether the T cell surface structure, T4 (Leu-3), is also involved in the lymphocyte adhesion to EC, adhesion assay was performed using nylon wool nonadherent lymphocytes in the presence of anti-Leu-2a or antiLeu-3a antibody which were extensively dialyzed to remove sodium azide affecting to increase lymphocyte adhesion nonspecifically. As shown in Fig. 9 , the lymphocyte adhesion to the EC was strongly blocked by anti-Leu-3a antibody, but not by antiLeu-2a antibody, at concentrations of 0.2-5 jsg/ml, thus suggesting that T4 antigens are indeed involved in the process of recognizing class II molecules expressed on EC.
Discussion
In this study, we demonstrated that unstimulated T cells, predominantly Leu-3' (helper/inducer) T cells, selectively adhered to EC that had been treated with rIFN--y, but not with rIFN-a, in both syngeneic and allogeneic combinations. Several Part of the trypsinized lymphocytes was further incubated for 12 h in a culture medium.
EC, whereas the adhesion of Leu-2+ T cells was only negligible.
The comparable degree of T cell-EC adhesion was observed in syngeneic combination to that in allogeneic combination, which suggests that such T cell-EC interaction is not merely the reflection of T cell-alloreactivity against class II antigens.
Recently, Collins et al. (28) reported that rIFN-'y induces HLA-DR, HLA-SB(DP), and HLA-DC(DQ) in human umbilical EC and dermal fibroblasts by transcription of apparently silent genes. In this study, we confirmed that almost all EC expressed the three sets of class II antigens on their surface when cultured It is now well established that the Leu-3' T subset interacts with class II antigens, whereas the Leu-2' T subset interacts with class I antigens. It is generally considered that an antigen-specific helper T cell receptor, in association with an antigen, recognizes a polymorphic determinant of Ia antigens, and that the interaction of a T4 (Leu-3) antigen on a helper T cell surface with a nonpolymorphic determinant of Ia antigens stabilizes and strengthens the receptor/ligand interactions (29) (30) (31) (33) (34) (35) . Janeway (36) recently proposed a more complex role of L3T4 molecules, in that the interaction ofthe murine L3T4 molecule In our preliminary investigations, the nonbound T cells harvested in both syngeneic and allogeneic EC adhesion experiments did not adhere to a second substrate in the syngeneic and allogeneic combinations. This, in turn, indicated that T cells adhering to either syngeneic or allogeneic EC are involved in the same subpopulation (-2-3% of added T cells) that recognizes a nonpolymorphic DR portion. The interaction between a T4 molecule and a nonpolymorphic DR portion may be an important initial event in T cell adhesion and motility on EC.
Indeed, if Leu-3' T cells adhere to EC by the interaction of the receptor on T cells with the class II antigens on EC, it would be somewhat puzzling why normal T cells do not adhere tightly to other class II antigen-bearing cells, such as B cells and macrophages. At least two explanations would be possible. First, class II antigens on B cells and macrophages may differ from those on EC quantitatively. As already noted, the intensity of DR antigen expression was the major factor determining the adhesiveness (Fig. 3) , and our preliminary results using a FACS analyzer indicated that the intensity of DR antigens on EC cultured with optimal doses ofrIFN-Ty was much higher than normal B cells and monocytes. Second, the extracellular matrix (ECM) of EC may be relevant to the T cell adhesion in addition to DR antigens because a change in the cell shape of the EC was always observed whenever lymphocytes adhered to the EC as shown in Table I . It is now clear that the ECM (e.g., fibronectin, several types of collagen, or glycosaminoglycans), plays an important role in cell adhesion, shape, and metabolic functions. For example, fibronectin was shown to mediate neutrophil adhesion to cultured EC (37, 38) . Recent studies also showed'that IFN-'y stimulated cultured EC to produce glycosaminoglycans (39), and T Cell Adhesion to Endothelial Cells through Endothelial DR Antigens 1603 1 that both increased fibronectin and Ia antigens were found on the EC in the target organ in acute experimental allergic encephalitis (EAE) (40) . Therefore, not only the expression ofclass II antigens, but also the supportive action of the ECM on EC may be required for the T cell adhesion to EC.
Although a small part of Leu-2+ cells or Leu-4-cells seemed to adhere to Ia-expressed EC, it remains unclear whether or not the adhesion was due to specific interactions with the EC.
In this study, we showed that lymphocytes treated with trypsin lost their capacity to bind to hi-expressed EC. These findings were in accord with previous studies that examined the effects oftrypsin on Iymphocyte homing in vivo and lymphocyte binding to HEV in vitro (41, 42 (6, 46) and in EAE (47) . However, the precise role of Ia-expression of EC in the target organ is still not completely understood. Considering the observations that Ia antigens were expressed on the involved vascular EC with predominant accumulation of T4' (helper/inducer) T cells in the graft dermis and graft bed in human skin allograft (6), it seems quite possible that a direct interaction of T4' cells with Ia molecules on EC may bring about such selective migration and accumulation. IFN-y is known to be secreted by activated T cells, and since the action of IFN-'y is supposed to be short-ranged, it would induce la antigens on surrounding vascular EC ofa limited area, in addition to other types of cells such as macrophages, thus creating "Ia-positive focus" around antigens. Ia-expressed EC in such foci would be expected to function in three aspects. First, they would provide sufficient antigenic presentation to antigen-reactive T cells to further initiate immune responses. Second, Ia-expressed EC would be damaged by the attack of allogeneic cytolytic T lymphocytes in allograft rejection (26, 34) . Third, Ia antigens would be expressed on the internal surface of microvessels with quantitative variations depending on the local concentration of IFN-'y produced in the foci. If Ia antigens on EC are strongly expressed, it should effectively facilitate the selective migration and accumulation of Ia-reactive T cells to the foci. Consequently, a sufficient amplification of local immune responses would be led.
The hypothesis mentioned above may explain one of the mechanisms operating in the following phenomenon. Steinman et al. (48) observed a decrease in the accumulation of lymphocytes in the central nervous system of an EAE mouse injected with monoclonal anti-Ia antibody. As a result, anti-Ia antibodies blocked the adhesion of Ia-reactive T cells to Ia-expressed EC, resulting in the inhibition of T cell migration from blood into the target organ.
It seems unlikely that such tight T cell-EC adhesion as demonstrated in this study occurred due to only the binding force between DR molcules and the complementary receptors. The T cell recognition of DR molecules may be the signal for the initiation of subsequent adhesion processes in which complementary adhesion surface molecules become engaged. Although certain cell surface molecules are regarded as being involved in lymphocyte adhesion reactions (11-15, 49) , it remains to be defined whether these molecules are also related to the T cell adhesion to Ia-expressed EC. At present, we do not know the changes of cellular membrane or metabolism that occur in the process of recognition and adhesion between T cells and EC, as well as the characteristics of acid-stable cytokines (other than IFN-y) such as those that enhance lymphocyte-EC binding as shown in Table II . The experiments to define these points are now in progress.
